• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    12/13/22 12:38:17 PM ET
    $ADIL
    $ALLR
    $ALR
    $AQMS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADIL alert in real time by email

     

    On Tuesday, 49 companies hit new 52-week lows.

    Key Facts About Today's 52-Week Lows:

    • Tesla (NASDAQ:TSLA) is the largest company in terms of market cap to set a new 52-week low this morning.
    • The smallest company by market cap to hit a new 52-week low was Quotient (NASDAQ:QTNT).
    • IMV (NASDAQ:IMV)'s stock fell the most, as it traded down 899.04% to reach a new 52-week low.
    • BiomX (AMEX:PHGE) shares bounced back the most, actually rising 0.05% after hiting a new 52-week low.

    On Tuesday, the following stocks broke to new 52-week lows:

    • Tesla (NASDAQ:TSLA) stock set a new 52-week low of $163.50 on Tuesday, moving down 0.29%.
    • Pacira BioSciences (NASDAQ:PCRX) stock set a new 52-week low of $42.53 on Tuesday, moving down 4.0%.
    • Nikola (NASDAQ:NKLA) shares reached a new 52-week low of $2.22 on Tuesday morning, moving down 2.14%.
    • Torrid Holdings (NYSE:CURV) shares were down 3.47% for the day, having made a 52-week low of $3.00.
    • AST SpaceMobile (NASDAQ:ASTS) stock achieved a new 52-week low on Tuesday morning, hitting $4.18 and moving down 1.14%.
    • Skillsoft (NYSE:SKIL) shares moved up 3.93% on Tuesday to hit a new 52-week low of $1.39, drifting up 3.93%.
    • Nautilus Biotechnology (NASDAQ:NAUT) stock broke to a new 52-week low of $1.60 on Tuesday. Shares of the company traded up 4.24%.
    • JOANN (NASDAQ:JOAN) shares hit a yearly low of $4.02. The stock was down 7.52% on the session.
    • Appreciate Holdings (NASDAQ:SFR) shares were down 0.8% for the day, having made a 52-week low of $1.80.
    • Quantum (NASDAQ:QMCO) stock achieved a new 52-week low on Tuesday morning, hitting $1.02 and moving up 0.56%.
    • Enzo Biochem (NYSE:ENZ) stock set a new 52-week low of $1.60 on Tuesday, moving down 12.13%.
    • Tempo Automation Holdings (NASDAQ:TMPO) shares moved up 0.5% on Tuesday to hit a new 52-week low of $1.81, drifting up 0.5%.
    • Aqua Metals (NASDAQ:AQMS) shares moved down 2.23% on Tuesday to hit a new 52-week low of $0.62, drifting down 2.23%.
    • Augmedix (NASDAQ:AUGX) shares set a new yearly low of $1.01 this morning. The stock was down 0.91% on the session.
    • LENSAR (NASDAQ:LNSR) shares fell to $2.96 on Tuesday, setting a new 52-week low with a shift of down 2.93%.
    • Salem Media Group (NASDAQ:SALM) shares set a new 52-week low of $1.13. The stock traded up 4.35%.
    • Jounce Therapeutics (NASDAQ:JNCE) shares fell to $0.59 on Tuesday, setting a new 52-week low with a shift of down 1.56%.
    • Senstar Tech (NASDAQ:SNT) shares set a new yearly low of $1.26 this morning. The stock was down 0.78% on the session.
    • MEI Pharma (NASDAQ:MEIP) stock hit $0.21 on Tuesday morning, setting a new 52-week low for a change of up 1.57%.
    • Hempacco (NASDAQ:HPCO) stock broke to a new 52-week low of $1.16 on Tuesday. Shares of the company traded up 3.42%.
    • Psychemedics (NASDAQ:PMD) shares reached a new 52-week low of $5.01 on Tuesday morning, moving down 0.4%.
    • Hepion Pharmaceuticals (NASDAQ:HEPA) stock set a new 52-week low of $0.32 on Tuesday, moving up 1.64%.
    • Clovis Oncology (NASDAQ:CLVS) shares fell to $0.16 on Tuesday, setting a new 52-week low with a shift of down 18.61%.
    • AlerisLife (NASDAQ:ALR) shares reached a new 52-week low of $0.72 on Tuesday morning, moving down 1.7%.
    • Lisata Therapeutics (NASDAQ:LSTA) shares moved down 1.99% on Tuesday to hit a new 52-week low of $2.87, drifting down 1.99%.
    • Codiak BioSciences (NASDAQ:CDAK) stock set a new 52-week low of $0.59 on Tuesday, moving down 2.2%.
    • Argo Blockchain (NASDAQ:ARBK) shares fell to $0.41 on Tuesday, setting a new 52-week low with a shift of down 37.49%.
    • Super League Gaming (NASDAQ:SLGG) stock drifted up 3.53% on Tuesday morning to hit a new 52-week low of $0.51.
    • TuanChe (NASDAQ:TC) stock hit a yearly low of $0.76. The stock was down 5.44% for the day.
    • Alterity Therapeutics (NASDAQ:ATHE) shares fell to $0.33 on Tuesday, setting a new 52-week low with a shift of down 0.44%.
    • Steakholder Foods (NASDAQ:STKH) shares set a new 52-week low of $0.85. The stock traded down 8.51%.
    • Lucira Health (NASDAQ:LHDX) stock broke to a new 52-week low of $0.27 on Tuesday. Shares of the company traded up 1.0%.
    • IM Cannabis (NASDAQ:IMCC) shares set a new yearly low of $1.51 this morning. The stock was up 0.97% on the session.
    • Ontrak (NASDAQ:OTRK) stock set a new 52-week low of $0.35 on Tuesday, moving up 3.93%.
    • NexImmune (NASDAQ:NEXI) shares made a new 52-week low of $0.30 on Tuesday. The stock was down 7.91% for the day.
    • Bellicum Pharmaceuticals (NASDAQ:BLCM) stock hit a new 52-week low of $0.90. The stock was down 3.17% on the session.
    • OceanPal (NASDAQ:OP) shares made a new 52-week low of $0.19 on Tuesday. The stock was up 2.51% for the day.
    • Adial Pharmaceuticals (NASDAQ:ADIL) shares set a new yearly low of $0.20 this morning. The stock was up 4.73% on the session.
    • BiomX (AMEX:PHGE) shares reached a new 52-week low of $0.18 on Tuesday morning, moving down 0.05%.
    • Universal Security (AMEX:UUU) shares moved down 0.58% on Tuesday to hit a new 52-week low of $2.15, drifting down 0.58%.
    • ContraFect (NASDAQ:CFRX) stock hit $0.11 on Tuesday morning, setting a new 52-week low for a change of down 10.85%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $0.36 on Tuesday morning, moving up 2.56%.
    • Bone Biologics (NASDAQ:BBLG) shares were down 15.37% for the day, having made a 52-week low of $0.20.
    • Quotient (NASDAQ:QTNT) stock hit a yearly low of $0.33. The stock was down 44.56% for the day.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ADIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADIL
    $ALLR
    $ALR
    $AQMS

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    AST SpaceMobile Inc.
    $ASTS
    1/13/2026$105.00Buy → Neutral
    B. Riley Securities
    Tesla Inc.
    $TSLA
    1/12/2026$120.00 → $130.00Underweight
    Wells Fargo
    AST SpaceMobile Inc.
    $ASTS
    1/7/2026$45.60Sector Perform → Sector Underperform
    Scotiabank
    Tesla Inc.
    $TSLA
    1/2/2026$444.00 → $439.00Hold
    Truist
    Pacira BioSciences Inc.
    $PCRX
    12/9/2025$27.00Equal Weight
    Barclays
    Tesla Inc.
    $TSLA
    12/8/2025$425.00Overweight → Equal-Weight
    Morgan Stanley
    AST SpaceMobile Inc.
    $ASTS
    11/24/2025$45.60Sector Underperform → Sector Perform
    Scotiabank
    More analyst ratings

    $ADIL
    $ALLR
    $ALR
    $AQMS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ault Milton C Iii bought $1,230,000 worth of shares (205,000 units at $6.00) (SEC Form 4)

    4 - UNIVERSAL SAFETY PRODUCTS, INC. (0000102109) (Issuer)

    2/6/26 4:30:08 PM ET
    $UUU
    Electronic Components
    Technology

    Director Ault Milton C Iii bought $570,000 worth of shares (95,000 units at $6.00) (SEC Form 4)

    4 - UNIVERSAL SAFETY PRODUCTS, INC. (0000102109) (Issuer)

    1/21/26 4:30:41 PM ET
    $UUU
    Electronic Components
    Technology

    Director Ault Milton C Iii bought $20,070 worth of shares (4,060 units at $4.94) (SEC Form 4)

    4 - UNIVERSAL SAFETY PRODUCTS, INC. (0000102109) (Issuer)

    1/2/26 6:04:20 AM ET
    $UUU
    Electronic Components
    Technology

    $ADIL
    $ALLR
    $ALR
    $AQMS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-11) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 06/10/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    6/13/22 2:20:18 PM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $ALLR
    $ALR
    $AQMS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst reiterated coverage on Tesla with a new price target

    Analyst reiterated coverage of Tesla with a rating of Underweight and set a new price target of $145.00 from $150.00 previously

    1/30/26 8:00:23 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    AST SpaceMobile downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded AST SpaceMobile from Buy to Neutral and set a new price target of $105.00

    1/13/26 9:00:28 AM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Wells Fargo reiterated coverage on Tesla with a new price target

    Wells Fargo reiterated coverage of Tesla with a rating of Underweight and set a new price target of $130.00 from $120.00 previously

    1/12/26 9:31:17 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $ADIL
    $ALLR
    $ALR
    $AQMS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    BRISBANE, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on February 3, 2026 to 14 new employees under Pacira's Amended and Restated 2014 Inducement Plan (the "Inducement Plan") as a material inducement to each employee's entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the People & Compensation Committee of the Board of Directors (the "Committee") without stockholder approval. Four employees received stock options to purchas

    2/9/26 8:00:00 AM ET
    $PCRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Defiance ETFs Launches ASTN: The First 2X Short ETF of AST SpaceMobile Inc.

    MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs is proud to announce the launch of the Defiance Daily Target 2X Short ASTS ETF (Ticker: ASTN), expanding its lineup of innovative single-stock leveraged ETFs designed for sophisticated traders seeking precision tools for short-term market expression. Investment Objective The Fund seeks daily inverse investment results, before fees and expenses, of -2 times (-200%) the daily percentage change in the share price of AST SpaceMobile, Inc. (NASDAQ:ASTS). The Fund does not seek to achieve its stated investment objective for a period other than a single trading day. Underlying Stock: AST SpaceMobile Inc. AST SpaceMobile, Inc. is developin

    2/6/26 8:31:00 AM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year 2025 before market open on Thursday, February 26, 2026. The company's management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the "Investors" section of the company website at: www.nautilus.bio. About Nautilus Biotechnology, Inc.With its corporate headquarters in Seattle,

    2/5/26 8:00:00 AM ET
    $NAUT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ADIL
    $ALLR
    $ALR
    $AQMS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ault Milton C Iii bought $1,230,000 worth of shares (205,000 units at $6.00) (SEC Form 4)

    4 - UNIVERSAL SAFETY PRODUCTS, INC. (0000102109) (Issuer)

    2/6/26 4:30:08 PM ET
    $UUU
    Electronic Components
    Technology

    Senior Vice President, Finance Riker Lauren covered exercise/tax liability with 2,751 shares and sold $83,240 worth of shares (4,000 units at $20.81), decreasing direct ownership by 11% to 52,313 units (SEC Form 4)

    4 - Pacira BioSciences, Inc. (0001396814) (Issuer)

    2/3/26 6:24:09 PM ET
    $PCRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Administrative Officer Williams Kristen covered exercise/tax liability with 17,134 shares and sold $269,703 worth of shares (13,137 units at $20.53), decreasing direct ownership by 19% to 131,303 units (SEC Form 4)

    4 - Pacira BioSciences, Inc. (0001396814) (Issuer)

    2/3/26 6:24:01 PM ET
    $PCRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $ALLR
    $ALR
    $AQMS
    SEC Filings

    View All

    Universal Safety Products Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - UNIVERSAL SAFETY PRODUCTS, INC. (0000102109) (Filer)

    2/6/26 4:30:57 PM ET
    $UUU
    Electronic Components
    Technology

    SEC Form 6-K filed by Token Cat Limited

    6-K - Token Cat Ltd (0001743340) (Filer)

    2/6/26 4:30:01 PM ET
    $TC
    Real Estate

    Amendment: SEC Form SCHEDULE 13G/A filed by Aqua Metals Inc.

    SCHEDULE 13G/A - Aqua Metals, Inc. (0001621832) (Subject)

    2/6/26 10:18:46 AM ET
    $AQMS
    Metal Fabrications
    Industrials

    $ADIL
    $ALLR
    $ALR
    $AQMS
    Leadership Updates

    Live Leadership Updates

    View All

    Quantum Appoints William H. White as Chief Financial Officer

    Seasoned finance executive brings growth-focused mindset to advancing Quantum's long-term strategy Quantum Corporation (NASDAQ:QMCO) today announced the appointment of William H. White as its Chief Financial Officer. White will lead Quantum's global finance organization, including financial strategy and operations, capital structure initiatives, and investor relations, supporting the company's next phase of growth and operational execution. White brings more than two decades of experience transforming technology companies through disciplined financial leadership and strategic capital allocation. He is recognized for improving operational rigor and modernizing reporting and forecasting p

    2/2/26 8:00:00 AM ET
    $QMCO
    Electronic Components
    Technology

    Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update

    − Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced − Highlights Phase 2 data for ATH434 in Multiple System Atrophy (MSA) strengthened by additional analyses and multiple international scientific presentations during the quarter.Regulatory planning activities advancing toward a pivotal Phase 3 program, including preparation for FDA End-Of-Phase-2 meeting in mid-2026.Ongoing partnering and strategic discussions with pharmaceutical companies and corporate advisers to explore non-dilutive pathways to fund Phase 3 development.Board and executive leadership strengthened to support Alterity through its next stage of clinical development, partnering and comme

    1/30/26 7:25:00 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors

    -- Veteran Executive Brings More Than 25 Years of Clinical Development and Industry Expertise -- BRISBANE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced the appointment of Samit Hirawat, M.D., to its Board of Directors. This appointment increases the size of the company's Board of Directors to 10 members. "Samit is an accomplished and widely respected leader in the biopharmaceutical industry, and we are pleased to welcome him to our Board of Directors," said Laura Brege, independent board chair of Pacira. "We believ

    1/28/26 8:00:00 AM ET
    $PCRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $ALLR
    $ALR
    $AQMS
    Financials

    Live finance-specific insights

    View All

    Defiance ETFs Launches ASTN: The First 2X Short ETF of AST SpaceMobile Inc.

    MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs is proud to announce the launch of the Defiance Daily Target 2X Short ASTS ETF (Ticker: ASTN), expanding its lineup of innovative single-stock leveraged ETFs designed for sophisticated traders seeking precision tools for short-term market expression. Investment Objective The Fund seeks daily inverse investment results, before fees and expenses, of -2 times (-200%) the daily percentage change in the share price of AST SpaceMobile, Inc. (NASDAQ:ASTS). The Fund does not seek to achieve its stated investment objective for a period other than a single trading day. Underlying Stock: AST SpaceMobile Inc. AST SpaceMobile, Inc. is developin

    2/6/26 8:31:00 AM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year 2025 before market open on Thursday, February 26, 2026. The company's management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the "Investors" section of the company website at: www.nautilus.bio. About Nautilus Biotechnology, Inc.With its corporate headquarters in Seattle,

    2/5/26 8:00:00 AM ET
    $NAUT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Tesla Fourth Quarter 2025 Production, Deliveries & Deployments

    In the fourth quarter, we produced over 434,000 vehicles, delivered over 418,000 vehicles and deployed 14.2 GWh of energy storage products – a record for deployments. Thank you to all of our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q4 2025   Production Deliveries Subject to operating lease accounting Model 3/Y 422,652 406,585 3% Other Models 11,706 11,642 5% Total 434,358 418,227 3% 2025   Production Deliveries Model 3/Y 1,600,767 1,585,279 Other Models 53,900 50,850

    1/2/26 9:07:00 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $ADIL
    $ALLR
    $ALR
    $AQMS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care